Cargando…
Biologics in Psoriasis: Updated Perspectives on Long-Term Safety and Risk Management
Biologics targeting Th1/Th17 cytokines have revolutionised psoriasis treatment. In addition to treatment effectiveness, it is important to define and understand the long-term risks of biologic therapy in order to guide therapy selection and minimise these risks for patients where possible. This revi...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747772/ https://www.ncbi.nlm.nih.gov/pubmed/35024352 http://dx.doi.org/10.2147/PTT.S328575 |